Home » Topics » BioWorld Science

BioWorld Science
RSS

Cadila Healthcare discloses new ACP1 inhibitors

April 8, 2022

Seoul Techno Holdings identifies new compounds for cancer

April 8, 2022

Elastrin Therapeutics closes funding round to advance development of lead candidate

April 8, 2022

1st Bio Therapeutics presents new protein kinase inhibitors

April 8, 2022

Novel HlyU inhibitor VM-17 attenuates the virulence of V. vulnificus

April 8, 2022

Researchers in China find evidence in mice that bacteria in tumors help cancer cells metastasize

April 8, 2022

PX-478 prevents rise of glycemia and improves beta-cell function in models diabetes

April 8, 2022

Jazz and Werewolf announce global license and collaboration agreement to develop WTX-613

April 8, 2022

Small molecule inhibitors of natural killer group 2D identified at Janssen

April 8, 2022

GPR30 is a therapeutic target in triple-negative inflammatory breast cancer

April 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...